Hrain Biotechnology Co., Ltd.
PrivateLast Round
Series C
Apr 26, 2021
Est. Valuation
$657M
Total Funding Raised
$118.99M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Hrain Biotechnology Co., Ltd. is a biotechnology company that specializes in the research, development, and manufacturing of breakthrough immune cell therapies, including CAR-T and CAR-NK products, for the treatment of hematologic malignancies and solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hrain Biotechnology Co., Ltd. Comparables
Compare Hrain Biotechnology Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Juventas Cell Therapy Ltd. | 87% | |
| PersonGen BioTherapeutics | 87% | |
| JW Therapeutics | 86% |
Hrain Biotechnology Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Apr 26, 2021 | ||||
| Series B Extension | Sep 8, 2020 | ||||
| Series B | Sep 30, 2019 | ||||
| Series A | Apr 1, 2018 |
Hrain Biotechnology Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Xinyi Capital | Series B Extension |
| Shenzhen Capital Group | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 404% MoM, from 284 to 1.4K.
- Apr 26, 2021
$62M round closed, valuing the company at $657M.
Hrain Biotechnology Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Hrain Biotechnology Co., Ltd.'s valuation, stock price, and market status.
Is Hrain Biotechnology Co., Ltd. a public or private company?
Hrain Biotechnology Co., Ltd. is a private company.
What is the current stock price of Hrain Biotechnology Co., Ltd.?
Hrain Biotechnology Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Hrain Biotechnology Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Hrain Biotechnology Co., Ltd. worth (valuation)?
Hrain Biotechnology Co., Ltd.'s valuation is estimated at $657.0M based on funding round data.
Can I buy Hrain Biotechnology Co., Ltd. stock?
Hrain Biotechnology Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Hrain Biotechnology Co., Ltd.'s last funding round?
Hrain Biotechnology Co., Ltd.'s most recent funding round was Series C on April 26, 2021.
Who are the main investors in Hrain Biotechnology Co., Ltd.?
Key investors in Hrain Biotechnology Co., Ltd. include Shenzhen Capital Group.
Will Hrain Biotechnology Co., Ltd. IPO soon?
No public IPO plans have been announced for Hrain Biotechnology Co., Ltd..
How can I track Hrain Biotechnology Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Hrain Biotechnology Co., Ltd.'s shares on secondary markets.